GE Discovery MI

Description

The GE Discovery MI PET/CT System represents a major leap forward in molecular imaging performance. By pairing digital detector technology with GE’s advanced CT platform, it delivers high spatial resolution, low-dose scanning, and outstanding quantitative accuracy. Built to meet the rigorous demands of leading cancer centers and high-throughput diagnostic facilities, the Discovery MI enables early disease identification, precise treatment response assessment, and optimal patient comfort.

Key Features

• Digital SiPM PET Detectors: High-density digital detectors with time-of-flight (TOF) capabilities deliver maximum photon efficiency and crisp spatial resolution.

• Q.Clear Digital Reconstruction: Advanced 3D reconstruction algorithm that enhances signal-to-noise ratio and provides up to 2x improvement in SUV quantitative accuracy.

• Smart MAR (Metal Artifact Reduction): Advanced CT technology that minimizes streak artifacts caused by medical implants or metallic objects.

• Ultra-Low Dose Protocols: Engineered to deliver high-clarity diagnostic images with significantly reduced radiotracer injection levels and lower CT radiation exposure.

• High-Speed Acquisition Engine: Enables rapid, full-body PET scans in a fraction of the time required by conventional analog systems.

Key Benefits

• Detection of Micro-Lesions: Exceptional digital resolution allows clinicians to spot small, subtle primary tumors and lymph node metastases earlier.

• Uncompromising Quantitative Accuracy: Precise SUV measurements enable oncologists to track treatment effectiveness over time with high confidence.

• Maximum Patient Safety: Significantly reduced radiotracer requirements lower overall radiation exposure for adult and pediatric patients alike.

• Enhanced Clinical Throughput: Rapid scan speeds shorten patient stay times, allowing imaging centers to comfortably handle high daily volume.

• Versatile Multidisciplinary Power: Excels across routine clinical oncology, cardiac viability studies, neurodegenerative disease evaluation, and clinical research.